BIB ETF: ProShares Ultra Nasdaq Biotechnology - Price, Holdings & Analysis
ProShares Ultra Nasdaq Biotechnology Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fund characteristics, expense ratio, dividend yield, and performance metrics
Frequently Asked Questions About ProShares Ultra Nasdaq Biotechnology
What is the current price of BIB?
The latest BIB price is $99.04. The 52-week range is $49.24–$110.25. BIB has returned 86.7% over the past 52 weeks.
What is the expense ratio for BIB?
BIB's annual expense ratio is 0.95%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equity ETFs in the ETF Screener.
Does BIB pay dividends?
Yes, BIB pays a 0.63% dividend yield. The last ex-dividend date was 2026-07-01. View full dividend history in the Dividends section.
What are the top holdings of BIB?
BIB's largest holdings are Gilead Sciences, Inc (4.9%), Vertex Pharmaceuticals Incorporated (4.8%), Amgen Inc. (4.7%) (combined weight: 14.4%). The fund holds 262 total positions. View the complete portfolio breakdown in the Holdings section.
How does BIB compare to similar ETFs?
Compare BIB (0.95% expense ratio, $70M AUM) against similar Equity ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.